Expertise in
1
conditions

Nianyong Chen

Cancer Center And State Key Laboratory Of Biotherapy, Department Of Radiation Oncology And Department Of Head And Neck Oncology, 
Chengdu, CN 
Expertise in
1
conditions
Cancer Center And State Key Laboratory Of Biotherapy, Department Of Radiation Oncology And Department Of Head And Neck Oncology, 
Chengdu, CN 
OverviewLocationsClinical Research

Overview

Nianyong Chen practices in Chengdu, China. Chen is highly rated in 1 condition, according to our data. Their top areas of expertise are Nasopharyngeal Carcinoma, Triple-Negative Breast Cancer, Cerebral Hypoxia, and Breast Cancer.

Their clinical research consists of co-authoring 56 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.

Locations

Cancer Center And State Key Laboratory Of Biotherapy, Department Of Radiation Oncology And Department Of Head And Neck Oncology, Chengdu, 610041, China
Other Locations
Department Of Head And Neck Oncology, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Randomized, Double-blind, Adaptive, Phase II/III Study of GSK3359609 or Placebo in Combination With Pembrolizumab for First-Line Treatment of PD-L1 Positive Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
A Randomized, Double-blind, Adaptive, Phase II/III Study of GSK3359609 or Placebo in Combination With Pembrolizumab for First-Line Treatment of PD-L1 Positive Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
Enrollment Status: Terminated
Publish Date: July 10, 2024
Intervention Type: Drug
Study Drugs: Feladilimab, Pembrolizumab
Study Phase: Phase 3

56 Total Publications

Bismuth-functionalized probiotics for enhanced antitumor radiotherapy and immune activation.
Bismuth-functionalized probiotics for enhanced antitumor radiotherapy and immune activation.
Journal: Journal of materials chemistry. B
Published: July 14, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Chen's expertise for a condition
ConditionClose
      View All 9 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile